Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) EBIT Margin (2016 - 2026)

Healthequity has reported EBIT Margin over the past 14 years, most recently at 21.24% for Q1 2026.

  • Quarterly results put EBIT Margin at 21.24% for Q1 2026, up 772.0% from a year ago — trailing twelve months through Jan 2026 was 24.55% (up 1102.0% YoY), and the annual figure for FY2026 was 24.55%, up 1102.0%.
  • EBIT Margin for Q1 2026 was 21.24% at Healthequity, down from 24.43% in the prior quarter.
  • Over the last five years, EBIT Margin for HQY hit a ceiling of 27.5% in Q3 2025 and a floor of 13.4% in Q1 2022.
  • Median EBIT Margin over the past 5 years was 12.4% (2023), compared with a mean of 11.14%.
  • Biggest five-year swings in EBIT Margin: tumbled -1256bps in 2022 and later surged 1906bps in 2023.
  • Healthequity's EBIT Margin stood at 2.56% in 2022, then soared by 383bps to 12.4% in 2023, then plummeted by -47bps to 6.53% in 2024, then skyrocketed by 274bps to 24.43% in 2025, then decreased by -13bps to 21.24% in 2026.
  • The last three reported values for EBIT Margin were 21.24% (Q1 2026), 24.43% (Q4 2025), and 27.5% (Q3 2025) per Business Quant data.